89bio, Inc
Why Robinhood?
You can watch 89bio, Inc and buy or sell other stocks, ETFs, and their options commission-free!About ETNB
89bio, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of innovative therapies for the treatment of liver and cardio-metabolic diseases. Its product pipeline includes pegozafermin, FGF21, NASH, and SHTG.
ETNB Key Statistics
Stock Snapshot
The current 89bio, Inc(ETNB) stock price is $14.84, with a market capitalization of 2.2B. The stock trades at a price-to-earnings (P/E) ratio of -4.12.
89bio, Inc(ETNB) stock opened on 2026-02-23 at —. The price climbed to — and dipped to —.
The 89bio, Inc(ETNB)'s current trading volume is 0, compared to an average daily volume of 7.1M.
In the last year, 89bio, Inc(ETNB) shares hit a 52-week high of $15.06 and a 52-week low of $4.16.
In the last year, 89bio, Inc(ETNB) shares hit a 52-week high of $15.06 and a 52-week low of $4.16.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.